Sherrie Perkins
Overview
Explore the profile of Sherrie Perkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shaw T, Pounds S, Cao X, Ma J, Palacios G, Mason J, et al.
Leukemia
. 2024 Nov;
39(1):199-210.
PMID: 39592809
Anaplastic large cell lymphoma (ALCL) is a mature T-cell lymphoma that accounts for 10-15% of childhood lymphomas. Despite the observation that more than 90% of pediatric cases harbor the anaplastic...
2.
Shaw T, Pounds S, Cao X, Ma J, Palacios G, Mason J, et al.
Res Sq
. 2024 Apr;
PMID: 38585847
Anaplastic large cell lymphoma (ALCL) is a mature T-cell lymphoma that accounts for for 10-15% of childhood lymphomas. Despite the observation that more than 90% of pediatric cases harbor the...
3.
Goldman S, Barth M, Shiramizu B, Shi Q, Hochberg J, Klejmont L, et al.
Leukemia
. 2021 May;
35(10):2994-2997.
PMID: 33941850
No abstract available.
4.
Guan J, Wang R, Hasan S, Tao L, Wazir M, Jain A, et al.
Cureus
. 2019 Jun;
11(4):e4401.
PMID: 31245191
Background The inhibition of programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1) signaling pathway has been shown to be an effective targeted therapy in fighting both solid organ cancers and...
5.
Sangle N, Cook J, Perkins S, Teman C, Bahler D, Hickman K, et al.
Appl Immunohistochem Mol Morphol
. 2014 Jun;
22(9):663-8.
PMID: 24897074
A fraction of polycythemia vera (PV) and essential thrombocythemia (ET) cases will, in time, undergo myelofibrotic transformation. In such cases, fibrosis may mask the diagnostic histologic features of the original...
6.
Barth M, Goldman S, Smith L, Perkins S, Shiramizu B, Gross T, et al.
Br J Haematol
. 2013 Jun;
162(5):678-83.
PMID: 23802659
The ANHL01P1 trial was undertaken to determine pharmacokinetics and safety following the addition of rituximab to French-American-British/Lymphome Malins de Burkitt (FAB/LMB96) chemotherapy in 41 children and adolescents with Stage III/IV...
7.
Vanhille D, Nussenzveig R, Glezos C, Perkins S, Agarwal A
Lab Hematol
. 2012 Sep;
18(3):17-9.
PMID: 23000486
The HEMOX Analyzer (TCS Scientific) has been used to measure the full oxygen-dissociation curve (ODC) and to calculate P(50) and the Hill coefficient. The effects of different anticoagulants on sample...
8.
Shiramizu B, Goldman S, Kusao I, Agsalda M, Lynch J, Smith L, et al.
Br J Haematol
. 2011 Apr;
153(6):758-63.
PMID: 21496005
Children/adolescents with mature B-cell non-Hodgkin lymphoma (B-NHL) have an excellent prognosis but relapses still occur. While chromosomal aberrations and/or clonal immunoglobulin (Ig) gene rearrangements may indicate risk of failure, a...
9.
Kelly K, Sposto R, Hutchinson R, Massey V, McCarten K, Perkins S, et al.
Blood
. 2010 Nov;
117(9):2596-603.
PMID: 21079154
Dose-intensified treatment strategies for Hodgkin lymphoma (HL) have demonstrated improvements in cure but may increase risk for acute and long-term toxicities, particularly in children. The Children's Oncology Group assessed the...
10.
Abromowitch M, Sposto R, Perkins S, Zwick D, Siegel S, Finlay J, et al.
Br J Haematol
. 2008 Sep;
143(2):261-7.
PMID: 18759768
Pediatric lymphoblastic lymphoma (LL) has utilized treatment strategies similar to childhood acute lymphoblastic leukaemia (ALL) with prolonged maintenance chemotherapy. We report the results of a pilot study to estimate the...